Dr. David-Alexandre C. Gros serves as the Chief Executive Officer and a member of the Board of Directors of Eledon Pharmaceuticals. Bringing extensive executive leadership experience from previous roles at prominent biopharmaceutical and healthcare enterprises, he oversees the company's strategic corporate direction, clinical development pipeline execution, and financial capitalization initiatives aimed at advancing its novel immunological therapies.